Press Releases
Announcement Follows Oversight Committee and Select Subcommittee Investigation into Company’s COVID-19 Vaccine Manufacturing Problems
Washington, D.C. (October 29, 2021) — Today, Rep. James E. Clyburn, Chairman of the Select Subcommittee on the Coronavirus Crisis, issued the following statement after the Food and Drug Administration (FDA) granted emergency use authorization (EUA) for the Pfizer/BioNTech coronavirus vaccine for children ages 5 to 11:
Clyburn Calls on Federal Trade Commission to Investigate America’s Frontline Doctors and SpeakWithAnMD.com for Deceptive Practices
Washington, D.C. (October 29, 2021) — Today, Rep. James E.
New Evidence Reveals that OSHA Made a “Political” Decision Not to Set Regulatory Standards that Would Have Protected Workers and Could Have Saved Lives
Washington, D.C. (October 27, 2021) — Today, the Select Subcommittee on the Coronavirus Crisis, chaired by Rep. James E.
Experts Urge Select Subcommittee Members to Continue Actions to Protect Workers
Washington, D.C. (October 27, 2021) — Today, the Select Subcommittee on the Coronavirus Crisis, chaired by Rep. James E.
Former President Trump’s Prioritization of the Election and Refusal to Follow the Science Resulted in the Loss of 130,000 Americans, Dr. Scott Atlas’s “Dangerous” Views Impaired Response
Washington, D.C. (October 26, 2021) — Today, Rep. James E. Clyburn, Chairman of the Select Subcommittee on the Coronavirus Crisis, released initial findings from transcribed interviews with former White House Coronavirus Response Coordinator Dr.
Chair Clyburn Calls on the USDA Inspector General to Scrutinize Wasted Funds After Year-Long Investigation Uncovers New Evidence of Waste and Abuse in $6 Billion Pandemic Food Program
Washington, D.C. (October 13, 2021) — Today, the Select Subcommittee on the Coronavirus Crisis, chaired by Rep. James E.